Diljit Kaur-Knudsen

Medicine & Life Sciences

1. Stevens-Johnson Syndrome 100%
2. Genotype 87%
3. Chronic Obstructive Pulmonary Disease 86%
4. Psoriasis 79%
5. Lung Diseases 72%
6. Tobacco 69%
7. prednylidene 59%
8. Erythema Multiforme 57%
9. Rosacea 56%
10. Breast Neoplasms 51%
11. Tobacco Use Disorder 49%
12. Smoking 47%
13. Population 47%
14. Penetrance 46%
15. Cytochrome P-450 CYP3A 46%
16. Nicotinic Receptors 44%
17. Patient Reported Outcome Measures 44%
18. Multigene Family 43%
19. Cytochrome P-450 CYP1B1 43%
20. Progesterone Receptors 42%
21. Biological Products 39%
22. Cytochrome P-450 Enzyme System 39%
23. Vascular Diseases 39%
24. Lung Neoplasms 38%
25. Estrogen Receptors 37%
26. Neoplasms 36%
27. Tumor Necrosis Factor Inhibitors 36%
28. Reproducibility of Results 36%
29. Pharmaceutical Preparations 33%
30. Blood Cells 33%
31. Chromosomes 32%
32. Referral and Consultation 29%
33. Cardiovascular Diseases 29%
34. Smokers 29%
35. Interleukin-17 28%
36. Genetic Variation 27%
37. Cohort Studies 27%
38. Genome-Wide Association Study 27%
39. Biomarkers 26%
40. Lung 26%
41. Mortality 25%
42. Cytokines 25%
43. Skin 24%
44. Inflammation 23%
45. Confidence Intervals 22%
46. Vital Capacity 22%
47. Forced Expiratory Volume 22%
48. Interleukin-6 20%
49. Lymphocytes 18%
50. Allopurinol 18%